Journal of Clinical Medicine (Sep 2023)

The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort

  • Alberto Floris,
  • Cristina Mugheddu,
  • Leonardo Sichi,
  • Martina Dessì,
  • Jasmine Anedda,
  • Alessia Frau,
  • Andrea Pau,
  • Simone Aldo Lari,
  • Jessica Sorgia,
  • Laura Li Volsi,
  • Maria Teresa Paladino,
  • Mattia Congia,
  • Elisabetta Chessa,
  • Maria Maddalena Angioni,
  • Caterina Ferreli,
  • Matteo Piga,
  • Laura Atzori,
  • Alberto Cauli

DOI
https://doi.org/10.3390/jcm12186090
Journal volume & issue
Vol. 12, no. 18
p. 6090

Abstract

Read online

Aiming to identify the potential challenges in the classification of musculoskeletal manifestations in patients with psoriasis (PsO), this study analyzed the outcomes of a cross-sectional rheumatologic assessment of 1057 PsO patients. In total, 209 had a previous diagnosis of psoriatic arthritis (PsA). Out of the remaining 848 subjects, 293 (35%) were classified as suspected PsA cases according to the rheumatologist’s judgment and/or Early PsA Screening Questionnaire score (EARP) ≥ 3. However, only 14% received a PsA diagnosis, 49% had a PsA-alternative diagnosis, and the remaining 37% had nonspecific arthralgias. Most of the newly diagnosed PsA patients had a symptoms duration ≥1 year (72%) and moderate disease activity (55%) with active oligoarthritis (85%), dactylitis, or enthesitis (35%) as the most frequent clinical pattern. The most frequent PsA-alternative diagnoses were osteoarthritis and fibromyalgia (44% and 41%). The only factors with significant (p < 0.05) utility in discriminating PsA from other diseases and nonspecific arthralgias were young age and EARP score with a history of morning stiffness, swollen joints, or dactylitis. These results demonstrated a high prevalence of suspected musculoskeletal symptoms in PsO patients, with, however, only a small proportion due to PsA. Close collaboration between the dermatologist and rheumatologist plays a crucial role in the differential diagnosis of PsA, as well as in monitoring nonspecific arthralgias for the potential transition to overt PsA.

Keywords